Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 7, 2015; 21(13): 3970-3977
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3970
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3970
Baseline characteristics | Value |
Age, yr | |
> 65 | 20 (15.2) |
≤ 65 | 112 (84.8) |
Gender | |
Male | 121 (91.7) |
Female | 11 (8.3) |
CLIP score | |
0 or 1 | 0 (0) |
2 | 38 (28.8) |
3 | 47 (35.6) |
4 | 47 (35.6) |
BCLC | |
A | 0 (0) |
B | 53 (40.2) |
C | 79 (59.8) |
D | 0 (0) |
ECOG Performance Status | |
0 | 87 (65.9) |
1 | 35 (26.5) |
2 | 10 (7.6) |
AFP, ng/mL (mean ± SD) | 15038.8 ± 22661.5 |
< 20 | 27 (20.5) |
20-400 | 23 (17.4) |
> 400 | 82 (62.1) |
Tumor nodules | |
Solitary | 110 (83.3) |
Multiple | 22 (16.7) |
Vascular invasion | |
With | 75 (56.8) |
Without | 57 (43.2) |
Extrahepatic metastasis | |
With | 40 (30.3) |
Without | 92 (69.7) |
Child-Pugh stage | |
A | 129 (97.7) |
B | 3 (2.3) |
HBV infection1 | |
Yes | 129 (97.7) |
No | 3 (2.3) |
HBV DNA level > 104 copies/mL | 50 (37.9) |
HCV antibody | |
Positive | 0 |
Negative | 132 (100) |
Cirrhosis | |
With | 124 (93.9) |
Without | 8 (6.1) |
- Citation: Li JH, Xie XY, Zhang L, Le F, Ge NL, Li LX, Gan YH, Chen Y, Zhang JB, Xue TC, Chen RX, Xia JL, Zhang BH, Ye SL, Wang YH, Ren ZG. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3970-3977
- URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3970.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3970